原发性甲状旁腺功能亢进症的三种表型:甲状旁腺切除术对所有人都有益吗?
该单中心回顾性研究纳入421例接受甲状旁腺切除术的原发性甲状旁腺功能亢进症患者,比较经典型、血钙正常型与激素正常型的临床结局。血钙正常型多腺体病变率更高,术后结石复发风险增加且持续性疾病比例更高,但骨密度有改善;激素正常型骨密度无显著变化。
要点
- 激素正常型术后骨密度基本稳定(0.2±14.2%),经典型与血钙正常型均有升高。
核心结论
- 原发性甲状旁腺功能亢进症三种生化表型是 distinct 临床实体,血钙正常型术后持续性疾病和结石复发风险更高但骨密度改善。
研究设计与样本
- 单中心回顾性综述,纳入421例接受甲状旁腺切除术的患者(经典型340例、血钙正常型39例、激素正常型42例),中位随访8.8个月(范围0-126)。
主要发现
- 术后并发症无差异。
- 首次术后双能X线吸收扫描骨密度最大百分比增幅:经典型6.4±9.1%,血钙正常型4.8±11.9%,激素正常型0.2±14.2%。
临床怎么用
- 术前应与血钙正常型和激素正常型患者讨论术后预期,包括持续性疾病和结石复发风险。
局限性
- 单中心回顾性设计,中位随访仅8.8个月,部分亚组样本量较小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary hyperparathyroidism consists of 3 biochemical phenotypes: classic, normocalcemic, and normohormonal primary hyperparathyroidism. The clinical outcomes of patients with normocalcemic primary hyperparathyroidism and normohormonal primary hyperparathyroidism are not well described. METHOD: A retrospective review of patients who underwent parathyroidectomy at a single institution was performed. A logistical regression analysis of postoperative nephrolithiasis and highest percentage change in dual-energy x-ray absorptiometry scan comparison using Kruskal-Wallis test and Cox proportional hazard analysis of recurrence-free survival were performed. RESULTS: A total of 421 patients were included (340 classic, 39 normocalcemic primary hyperparathyroidism, 42 normohormonal primary hyperparathyroidism). Median follow-up was 8.8 months (range 0-126). Higher rates of multigland disease were seen in normocalcemic primary hyperparathyroidism (64.1%) and normohormonal primary hyperparathyroidism (56.1%) compared to the classic (25.8%), P < .001. There were no differences in postoperative complications. The largest percentage increases in bone mineral density at the first postoperative dual-energy x-ray absorptiometry scan were higher for classic (mean ± SD, 6.4 ± 9.1) and normocalcemic primary hyperparathyroidism (4.8 ± 11.9) compared to normohormonal primary hyperparathyroidism, which remained stable (0.2 ± 14.2). Normocalcemic primary hyperparathyroidism were more likely to experience nephrolithiasis postoperatively, 6/13 (46.2%) compared to 11/68 (16.2%) classic, and 2/13 (15.4%) normohormonal primary hyperparathyroidism, P = .0429. Normocalcemic primary hyperparathyroidism was the only univariate predictor of postoperative nephrolithiasis recurrence (odds ratio [95% confidence interval] 4.44 [1.25-15.77], P = .029). Normocalcemic primary hyperparathyroidism was significantly associated with persistent disease with 6/32 (18.8%) compared to 1/36 (2.8%) and 3/252 (1.2%) in normohormonal primary hyperparathyroidism and classic (P < .001). CONCLUSION: Three phenotypes of primary hyperparathyroidism are distinct clinical entities. Normocalcemic primary hyperparathyroidism had higher incidence of persistent disease and postoperative nephrolithiasis but demonstrated improvements in postoperative bone density. These data should inform preoperative discussions with patients with normocalcemic primary hyperparathyroidism and normohormonal primary hyperparathyroidism regarding postoperative expectations.
引用
- Armstrong VL, Hangge PT, Butterfield R, et al. Phenotypes of primary hyperparathyroidism: Does parathyroidectomy improve clinical outcomes for all? Surgery. 2022. PMID: 36244815. doi:10.1016/j.surg.2022.05.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。